Candidemia in COVID-19 treated with corticosteroids and tocilizumab

Koichiro Yamamoto; Kaoru Nakamura; Hideharu Hagiya; Fumio Otsuka

doi:10.1002/ccr3.4858

Candidemia in COVID-19 treated with corticosteroids and tocilizumab

Koichiro Yamamoto, Kaoru Nakamura, Hideharu Hagiya, Fumio Otsuka

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

COVID-19 patients treated with anti-inflammatory drugs are rarely complicated by candidemia. Since immunosuppressive therapy can blunt inflammatory reactions, clinicians should actively survey latent candidemia during severe COVID-19 treatment.

Original language	English
Article number	e04858
Journal	Clinical Case Reports
Volume	9
Issue number	9
DOIs	https://doi.org/10.1002/ccr3.4858
Publication status	Published - Sept 2021

Keywords

SARS-CoV-2
candidemia
coronavirus disease 2019
corticosteroid
tocilizumab

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1002/ccr3.4858

Cite this

@article{b4a14a67210a47109137d545d63d31c5,

title = "Candidemia in COVID-19 treated with corticosteroids and tocilizumab",

abstract = "COVID-19 patients treated with anti-inflammatory drugs are rarely complicated by candidemia. Since immunosuppressive therapy can blunt inflammatory reactions, clinicians should actively survey latent candidemia during severe COVID-19 treatment.",

keywords = "SARS-CoV-2, candidemia, coronavirus disease 2019, corticosteroid, tocilizumab",

author = "Koichiro Yamamoto and Kaoru Nakamura and Hideharu Hagiya and Fumio Otsuka",

note = "Funding Information: None Publisher Copyright: {\textcopyright} 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.",

year = "2021",

month = sep,

doi = "10.1002/ccr3.4858",

language = "English",

volume = "9",

journal = "Clinical Case Reports",

issn = "2050-0904",

publisher = "John Wiley and Sons Ltd",

number = "9",

}

TY - JOUR

T1 - Candidemia in COVID-19 treated with corticosteroids and tocilizumab

AU - Yamamoto, Koichiro

AU - Nakamura, Kaoru

AU - Hagiya, Hideharu

AU - Otsuka, Fumio

PY - 2021/9

Y1 - 2021/9

N2 - COVID-19 patients treated with anti-inflammatory drugs are rarely complicated by candidemia. Since immunosuppressive therapy can blunt inflammatory reactions, clinicians should actively survey latent candidemia during severe COVID-19 treatment.

AB - COVID-19 patients treated with anti-inflammatory drugs are rarely complicated by candidemia. Since immunosuppressive therapy can blunt inflammatory reactions, clinicians should actively survey latent candidemia during severe COVID-19 treatment.

KW - SARS-CoV-2

KW - candidemia

KW - coronavirus disease 2019

KW - corticosteroid

KW - tocilizumab

UR - http://www.scopus.com/inward/record.url?scp=85115683747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85115683747&partnerID=8YFLogxK

U2 - 10.1002/ccr3.4858

DO - 10.1002/ccr3.4858

M3 - Article

AN - SCOPUS:85115683747

SN - 2050-0904

VL - 9

JO - Clinical Case Reports

JF - Clinical Case Reports

IS - 9

M1 - e04858

ER -

Candidemia in COVID-19 treated with corticosteroids and tocilizumab

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this